These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7937713)

  • 1. Humanization of 60.3, an anti-CD18 antibody; importance of the L2 loop.
    Hsiao KC; Bajorath J; Harris LJ
    Protein Eng; 1994 Jun; 7(6):815-22. PubMed ID: 7937713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humanization of the anti-CD18 antibody 6.7: an unexpected effect of a framework residue in binding to antigen.
    Caldas C; Coelho V; Kalil J; Moro AM; Maranhão AQ; Brígido MM
    Mol Immunol; 2003 May; 39(15):941-52. PubMed ID: 12695120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of germline-based hemi-humanized single-chain Fv against the CD18 surface antigen.
    Caldas C; Coelho VP; Rigden DJ; Neschich G; Moro AM; Brígido MM
    Protein Eng; 2000 May; 13(5):353-60. PubMed ID: 10835109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humanization of an anti-lymphocyte function-associated antigen (LFA)-1 monoclonal antibody and reengineering of the humanized antibody for binding to rhesus LFA-1.
    Werther WA; Gonzalez TN; O'Connor SJ; McCabe S; Chan B; Hotaling T; Champe M; Fox JA; Jardieu PM; Berman PW; Presta LG
    J Immunol; 1996 Dec; 157(11):4986-95. PubMed ID: 8943405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse/human chimeric Me1-14 antibody: genomic cloning of the variable region genes, linkage to human constant region genes, expression, and characterization.
    Batra SK; Niswonger ML; Wikstrand CJ; Pegram CN; Zalutsky MR; Morrison SL; Bigner DD
    Hybridoma; 1994 Apr; 13(2):87-97. PubMed ID: 8050781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humanization by variable domain resurfacing and grafting on a human IgG4, using a new approach for determination of non-human like surface accessible framework residues based on homology modelling of variable domains.
    Staelens S; Desmet J; Ngo TH; Vauterin S; Pareyn I; Barbeaux P; Van Rompaey I; Stassen JM; Deckmyn H; Vanhoorelbeke K
    Mol Immunol; 2006 Mar; 43(8):1243-57. PubMed ID: 16118019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humanization of murine monoclonal antibodies through variable domain resurfacing.
    Roguska MA; Pedersen JT; Keddy CA; Henry AH; Searle SJ; Lambert JM; Goldmacher VS; Blättler WA; Rees AR; Guild BC
    Proc Natl Acad Sci U S A; 1994 Feb; 91(3):969-73. PubMed ID: 8302875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humanization and pharmacokinetics of a monoclonal antibody with specificity for both E- and P-selectin.
    He XY; Xu Z; Melrose J; Mullowney A; Vasquez M; Queen C; Vexler V; Klingbeil C; Co MS; Berg EL
    J Immunol; 1998 Jan; 160(2):1029-35. PubMed ID: 9551944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimerization of LL2, a rapidly internalizing antibody specific for B cell lymphoma.
    Leung SO; Shevitz J; Pellegrini MC; Dion AS; Shih LB; Goldenberg DM; Hansen HJ
    Hybridoma; 1994 Dec; 13(6):469-76. PubMed ID: 7737671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human-engineered monoclonal antibodies retain full specific binding activity by preserving non-CDR complementarity-modulating residues.
    Studnicka GM; Soares S; Better M; Williams RE; Nadell R; Horwitz AH
    Protein Eng; 1994 Jun; 7(6):805-14. PubMed ID: 7937712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
    Wu H; Nie Y; Huse WD; Watkins JD
    J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humanization of mouse anti-human IL-2 receptor antibody B-B10.
    Nakatani T; Lone YC; Yamakawa J; Kanaoka M; Gomi H; Wijdenes J; Noguchi H
    Protein Eng; 1994 Mar; 7(3):435-43. PubMed ID: 8177893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humanization of a mouse monoclonal antibody by CDR-grafting: the importance of framework residues on loop conformation.
    Kettleborough CA; Saldanha J; Heath VJ; Morrison CJ; Bendig MM
    Protein Eng; 1991 Oct; 4(7):773-83. PubMed ID: 1798701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Framework residues 71 and 93 of the chimeric B72.3 antibody are major determinants of the conformation of heavy-chain hypervariable loops.
    Xiang J; Sha Y; Jia Z; Prasad L; Delbaere LT
    J Mol Biol; 1995 Oct; 253(3):385-90. PubMed ID: 7473721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary sequence and molecular model of the variable region of a mouse monoclonal anti-Der p 1 antibody showing a similar epitope specificity as human IgE.
    McElveen JE; Clark MR; Smith SJ; Sewell HF; Shakib F
    Clin Exp Allergy; 1998 Nov; 28(11):1427-34. PubMed ID: 9824417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning of cDNAs encoding the variable domains of antibody KC4G3 and construction of a chimeric antibody.
    Couto JR; Blank EW; Peterson JA; Ceriani RL
    Hybridoma; 1993 Aug; 12(4):485-9. PubMed ID: 8244420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular modeling and preclinical evaluation of the humanized NR-LU-13 antibody.
    Graves SS; Goshorn SC; Stone DM; Axworthy DB; Reno JM; Bottino B; Searle S; Henry A; Pedersen J; Rees AR; Libby RT
    Clin Cancer Res; 1999 Apr; 5(4):899-908. PubMed ID: 10213227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymerase chain reaction facilitates the cloning, CDR-grafting, and rapid expression of a murine monoclonal antibody directed against the CD18 component of leukocyte integrins.
    Daugherty BL; DeMartino JA; Law MF; Kawka DW; Singer II; Mark GE
    Nucleic Acids Res; 1991 May; 19(9):2471-6. PubMed ID: 1674999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humanization of a mouse antibody against human alpha-4 integrin: a potential therapeutic for the treatment of multiple sclerosis.
    Léger OJ; Yednock TA; Tanner L; Horner HC; Hines DK; Keen S; Saldanha J; Jones ST; Fritz LC; Bendig MM
    Hum Antibodies; 1997; 8(1):3-16. PubMed ID: 9265500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of two murine monoclonal antibodies humanized by CDR-grafting and variable domain resurfacing.
    Roguska MA; Pedersen JT; Henry AH; Searle SM; Roja CM; Avery B; Hoffee M; Cook S; Lambert JM; Blättler WA; Rees AR; Guild BC
    Protein Eng; 1996 Oct; 9(10):895-904. PubMed ID: 8931129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.